Safety and efficacy results from an international Expanded Access Programme to bortezomib for patients with relapsed and/or refractory multiple myeloma: A subset analysis of the Australian and New Zealand data of 111 patients

H. Quach, N. Horvath, P. Cannell, J. R. Mikhael, B. E. Butcher, H. M. Prince

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy results from an international Expanded Access Programme to bortezomib for patients with relapsed and/or refractory multiple myeloma: A subset analysis of the Australian and New Zealand data of 111 patients'. Together they form a unique fingerprint.

Medicine & Life Sciences